Resumo
Definição
História e exame físico
Principais fatores diagnósticos
- digoxin exposure
- gastrointestinal symptoms
- central nervous system symptoms
- visual symptoms
Outros fatores diagnósticos
- suicidality
- cardiovascular symptoms
Fatores de risco
- age >55 years
- decreased renal clearance
- hyperkalemia (>5.0 mEq/L)
- hypokalemia (<3.0 to 3.5 mEq/L)
- concomitant use of specific drugs
- hypomagnesemia
- hypercalcemia
- hypothyroidism
Investigações diagnósticas
Primeiras investigações a serem solicitadas
- ECG
- digoxin serum concentration
- serum potassium level
- serum magnesium level
- serum creatinine and BUN
Algoritmo de tratamento
acute ingestion, low to moderate toxicity
chronic ingestion, low to moderate toxicity
severe toxicity or hemodynamic compromise (acute or chronic toxicity)
acute or chronic toxicity after initial treatment
Colaboradores
Autores
Scott Phillips, MD
Associate Clinical Professor of Medicine
Department of Clinical Pharmacology and Toxicology
University of Colorado
Denver
CO
Associate Medical Director
Washington Poison Center
Seattle
WA
Divulgaciones
SP declares that he has no competing interests.
Agradecimientos
Dr Scott Phillips would like to gratefully acknowledge Dr Oladapo A. Odujube and Dr Robert S. Hoffman, previous contributors to this topic.
Divulgaciones
OAO and RSH declare that they have no competing interests.
Revisores por pares
Edward W. Boyer, MD
University of Massachusetts Medical School
Worcester
MA
Divulgaciones
EWB declares that he has no competing interests.
Ruben Thanacoody, MD, FRCP(Edin)
Consultant Physician and Clinical Toxicologist
National Poisons Information Service (Newcastle)
Newcastle-upon-Tyne
UK
Divulgaciones
RT declares that he has no competing interests.
Peer reviewer acknowledgements
BMJ Best Practice topics are updated on a rolling basis in line with developments in evidence and guidance. The peer reviewers listed here have reviewed the content at least once during the history of the topic.
Disclosures
Peer reviewer affiliations and disclosures pertain to the time of the review.
Referencias
Artículos principales
Gheorghiade M, van Veldhuisen DJ, Colucci WS. Contemporary use of digoxin in the management of cardiovascular disorders. Circulation. 2006 May 30;113(21):2556-64. Resumen
Smith TW, Haber E, Yeatman L, et al. Reversal of advanced digoxin intoxication with Fab fragments of digoxin-specific antibodies. N Engl J Med. 1976 Apr 8;294(15):797-800. Resumen
Smith TW, Butler VP Jr, Haber E, et al. Treatment of life-threatening digitalis intoxication with digoxin-specific Fab antibody fragments: experience in 26 cases. N Engl J Med. 1982 Nov 25;307(22):1357-62. Resumen
Bismuth C, Gaultier M, Conso F, et al. Hyperkalemia in acute digitalis poisoning: prognostic significance and therapeutic implications. Clin Toxicol. 1973;6(2):153-62. Resumen
Taboulet P, Baud FJ, Bismuth C, et al. Acute digitalis intoxication--is pacing still appropriate? J Toxicol Clin Toxicol. 1993;31(2):261-73. Resumen
Artículos de referencia
Una lista completa de las fuentes a las que se hace referencia en este tema está disponible para los usuarios con acceso a todo BMJ Best Practice.
Diferenciales
- Beta-blocker toxicity
- Calcium-channel blocker toxicity
- Clonidine toxicity
Más DiferencialesGuías de práctica clínica
- 2018 ACC/AHA/HRS Guideline on the evaluation and management of patients with bradycardia and cardiac conduction delay
- Position statement and practice guidelines on the use of multi-dose activated charcoal in the treatment of acute poisoning
Más Guías de práctica clínicaFolletos para el paciente
Heart attack
Heart failure
Más Folletos para el pacienteInicie sesión o suscríbase para acceder a todo el BMJ Best Practice
El uso de este contenido está sujeto a nuestra cláusula de exención de responsabilidad